204 related articles for article (PubMed ID: 11216555)
1. Intraperitoneal infusion of glucose-based dialysate in the rat--an animal model for the study of peritoneal advanced glycation end-products formation and effect on peritoneal transport.
Zeltzer E; Klein O; Rashid G; Katz D; Korzets Z; Bernheim J
Perit Dial Int; 2000; 20(6):656-61. PubMed ID: 11216555
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycosylation end-products in diabetic rats on peritoneal dialysis using various solutions.
Lee JH; Reddy DK; Saran R; Moore HL; Twardowski ZJ; Nolph KD; Khanna R
Perit Dial Int; 2000; 20(6):643-51. PubMed ID: 11216553
[TBL] [Abstract][Full Text] [Related]
3. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat.
Park SH; Lee EG; Kim IS; Kim YJ; Cho DK; Kim YL
Perit Dial Int; 2004; 24(2):115-22. PubMed ID: 15119632
[TBL] [Abstract][Full Text] [Related]
4. Effects of bicarbonate/lactate solution on peritoneal advanced glycosylation end-product accumulation.
Park MS; Kim JK; Holmes C; Weiss MF
Perit Dial Int; 2000; 20 Suppl 5():S33-8. PubMed ID: 11229610
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal accumulation of advanced glycosylation end-products in diabetic rats on dialysis with icodextrin.
Lee JH; Reddy DK; Saran R; Moore HL; Twardowski ZJ; Nolph KD; Khanna R
Perit Dial Int; 2000; 20 Suppl 5():S39-47. PubMed ID: 11229611
[TBL] [Abstract][Full Text] [Related]
6. The effect of advanced glycation end-products and aminoguanidine on TNFalpha production by rat peritoneal macrophages.
Rashid G; Luzon AA; Korzets Z; Klein O; Zeltzer E; Bernheim J
Perit Dial Int; 2001; 21(2):122-9. PubMed ID: 11330554
[TBL] [Abstract][Full Text] [Related]
7. Daily exposure to dialysis fluid results in changes in peritoneal transport.
Wang T; Qureshi AR; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Perit Dial Int; 1997; 17(4):379-86. PubMed ID: 9284466
[TBL] [Abstract][Full Text] [Related]
8. Does enalapril prevent peritoneal fibrosis induced by hypertonic (3.86%) peritoneal dialysis solution?
Duman S; Günal AI; Sen S; Asçi G; Ozkahya M; Terzioglu E; Akçiçek F; Atabay G
Perit Dial Int; 2001; 21(2):219-24. PubMed ID: 11330572
[TBL] [Abstract][Full Text] [Related]
9. Amadori albumin and advanced glycation end-product formation in peritoneal dialysis using icodextrin.
Posthuma N; ter Wee PM; Niessen H; Donker AJ; Verbrugh HA; Schalkwijk CG
Perit Dial Int; 2001; 21(1):43-51. PubMed ID: 11280495
[TBL] [Abstract][Full Text] [Related]
10. Physiological saline is not a biocompatible peritoneal dialysis solution.
Wang T; Heimbürger O; Qureshi AR; Waniewski J; Bergström J; Lindholm B
Int J Artif Organs; 1999 Feb; 22(2):88-93. PubMed ID: 10212043
[TBL] [Abstract][Full Text] [Related]
11. Low glucose degradation product peritoneal dialysis regimen is associated with lower plasma EN-RAGE and HMGB-1 proinflammatory ligands of receptor for advanced glycation end products.
Opatrna S; Popperlova A; Kalousová M; Zima T
Ther Apher Dial; 2014 Jun; 18(3):309-16. PubMed ID: 24965297
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products are associated with immature angiogenesis and peritoneal dysfunction in patients on peritoneal dialysis.
Nakano T; Mizumasa T; Kuroki Y; Eriguchi M; Yoshida H; Taniguchi M; Masutani K; Tsuruya K; Kitazono T
Perit Dial Int; 2020 Jan; 40(1):67-75. PubMed ID: 32063152
[TBL] [Abstract][Full Text] [Related]
13. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
[TBL] [Abstract][Full Text] [Related]
14. The effect of dialysate acidity on peritoneal solute transport in the rat.
Park MS; Heimbürger O; Waniewski J; Werynski A; Lee HB; Bergström J; Lindholm B
Perit Dial Int; 1995; 15(8):312-9. PubMed ID: 8785228
[TBL] [Abstract][Full Text] [Related]
15. Comparison of three chronic dialysis models.
Peng WX; Guo QY; Liu SM; Liu CZ; Lindholm B; Wang T
Adv Perit Dial; 2000; 16():51-4. PubMed ID: 11045261
[TBL] [Abstract][Full Text] [Related]
16. The breakdown of preformed peritoneal advanced glycation end products by intraperitoneal alagebrium.
Lee YK; Lee JY; Kim JS; Won KB; Kang HJ; Jang TJ; Tak WT; Lee JH
J Korean Med Sci; 2009 Jan; 24 Suppl(Suppl 1):S189-94. PubMed ID: 19194551
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal accumulation of AGE and peritoneal membrane permeability.
Park MS; Lee HA; Chu WS; Yang DH; Hwang SD
Perit Dial Int; 2000; 20(4):452-60. PubMed ID: 11007378
[TBL] [Abstract][Full Text] [Related]
18. Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis.
Pecoits-Filho R; Carvalho MJ; Stenvinkel P; Lindholm B; Heimbürger O
Perit Dial Int; 2006; 26(1):53-63. PubMed ID: 16538876
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.
Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Kidney Int; 1998 Feb; 53(2):496-502. PubMed ID: 9461112
[TBL] [Abstract][Full Text] [Related]
20. Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats.
Połubinska A; Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Chen C; Moberly JB; Martis L; Breborowicz A; Oreopoulos DG
Kidney Int; 2000 Mar; 57(3):1182-9. PubMed ID: 10720971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]